What is the equity of Laboratory Corporation of America Holdings this year?
Laboratory Corporation of America Holdings has equity of 7.88 B USD this year.
Laboratory Corporation of America Holdings Equity 2024
Laboratory Corporation of America Holdings Equity
7.88 B USD
Ticker
LH
ISIN
US50540R4092
WKN
895308
In 2024, Laboratory Corporation of America Holdings's equity was 7.88 B USD, a -22% increase from the 10.1 B USD equity in the previous year.
Laboratory Corporation of America Holdings Aktienanalyse
What does Laboratory Corporation of America Holdings do?
The Laboratory Corporation of America Holdings, also known as LabCorp, is an American company that has been operating in the medical diagnostics industry since 1978. It was founded by a doctor and a laboratory scientist with the goal of simplifying and improving the diagnostic process. LabCorp is now the largest independent diagnostic company in the world, with over 60,000 employees. LabCorp's business model is to contribute to the prevention, diagnosis, and treatment of diseases through its comprehensive diagnostic services. The company offers a wide range of medical laboratory tests, clinical studies, and DNA analysis services. LabCorp operates more than 2,000 locations in the United States, Canada, and Europe, and provides its services worldwide. LabCorp is divided into three business segments: Diagnostics, Drug Development, and CRO (contract research organization). Under the Diagnostics segment, the company offers laboratory tests for clinical detection, cancer diagnosis, genetic testing, and more. The company specializes in blood, body fluid, and tissue analyses and also offers a variety of specialized tests to answer specific medical questions. LabCorp's Drug Development segment aims to accelerate and improve drug development through its comprehensive clinical studies. The company assists with study coordination and compliance with regulatory requirements to ensure accurate and reliable study results. LabCorp's CRO segment offers clinical study services, including study planning, design, execution, and analysis. This enables the company to develop groundbreaking treatment options for diseases that do not yet have adequate therapies. LabCorp is also heavily involved in the development of personalized diagnostics to provide patients with even more accurate diagnosis and treatment options. LabCorp offers a wide range of products. The company is a leading provider of clinical laboratory services and offers a broad range of laboratory tests for infections, hormonal disorders, autoimmune diseases, allergies, and cancer. Some of the specialized tests offered by LabCorp include genetic testing for cancer diagnosis and inherited metabolic disorders. In the Drug Development segment, the company offers a wide range of clinical studies aimed at developing new drugs and therapies. LabCorp also utilizes its DNA identification services to confirm the identity of individuals or assist in forensic cases. In summary, LabCorp is a successful company specialized in medical diagnostics. Over the past 40 years, the company has experienced impressive growth and positioned itself as a leading provider of clinical laboratory services. With its wide range of diagnostic services, clinical studies, and DNA identification services, LabCorp provides innovative solutions for the medical challenges of the future. Laboratory Corporation of America Holdings ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Laboratory Corporation of America Holdings's Equity
Laboratory Corporation of America Holdings's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Laboratory Corporation of America Holdings's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Laboratory Corporation of America Holdings's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Laboratory Corporation of America Holdings's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Laboratory Corporation of America Holdings’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Laboratory Corporation of America Holdings stock
What was the equity of Laboratory Corporation of America Holdings compared to the previous year?
The equity of Laboratory Corporation of America Holdings has increased/decreased by -22% decreased compared to the previous year.
What impact does a high equity have on investors of Laboratory Corporation of America Holdings?
A high equity is advantageous for investors of Laboratory Corporation of America Holdings as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Laboratory Corporation of America Holdings?
A low equity can be a risk for investors of Laboratory Corporation of America Holdings, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Laboratory Corporation of America Holdings affect the company?
An increase in equity of Laboratory Corporation of America Holdings can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Laboratory Corporation of America Holdings affect the company?
A reduction in equity of Laboratory Corporation of America Holdings can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Laboratory Corporation of America Holdings?
Some factors that can affect the equity of Laboratory Corporation of America Holdings include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Laboratory Corporation of America Holdings so important for investors?
The equity of Laboratory Corporation of America Holdings is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Laboratory Corporation of America Holdings take to change the equity?
To change equity, Laboratory Corporation of America Holdings can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Laboratory Corporation of America Holdings pay?
Over the past 12 months, Laboratory Corporation of America Holdings paid a dividend of 2.88 USD . This corresponds to a dividend yield of about 1.29 %. For the coming 12 months, Laboratory Corporation of America Holdings is expected to pay a dividend of 3.19 USD.
What is the dividend yield of Laboratory Corporation of America Holdings?
The current dividend yield of Laboratory Corporation of America Holdings is 1.29 %.
When does Laboratory Corporation of America Holdings pay dividends?
Laboratory Corporation of America Holdings pays a quarterly dividend. This is distributed in the months of March, June, June, September.
How secure is the dividend of Laboratory Corporation of America Holdings?
Laboratory Corporation of America Holdings paid dividends every year for the past 7 years.
What is the dividend of Laboratory Corporation of America Holdings?
For the upcoming 12 months, dividends amounting to 3.19 USD are expected. This corresponds to a dividend yield of 1.43 %.
In which sector is Laboratory Corporation of America Holdings located?
Laboratory Corporation of America Holdings is assigned to the 'Health' sector.
Wann musste ich die Aktien von Laboratory Corporation of America Holdings kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Laboratory Corporation of America Holdings from 9/13/2024 amounting to 0.72 USD, you needed to have the stock in your portfolio before the ex-date on 8/29/2024.
When did Laboratory Corporation of America Holdings pay the last dividend?
The last dividend was paid out on 9/13/2024.
What was the dividend of Laboratory Corporation of America Holdings in the year 2023?
In the year 2023, Laboratory Corporation of America Holdings distributed 2.16 USD as dividends.
In which currency does Laboratory Corporation of America Holdings pay out the dividend?
The dividends of Laboratory Corporation of America Holdings are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Laboratory Corporation of America Holdings
Our stock analysis for Laboratory Corporation of America Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Laboratory Corporation of America Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Laboratory Corporation of America Holdings Revenue
- Laboratory Corporation of America Holdings Net Income
- Laboratory Corporation of America Holdings P/E
- Laboratory Corporation of America Holdings P/S
- Laboratory Corporation of America Holdings EBIT
- Laboratory Corporation of America Holdings Dividend
- Laboratory Corporation of America Holdings Stocks
- Laboratory Corporation of America Holdings Market capitalization
- Laboratory Corporation of America Holdings Debt
- Laboratory Corporation of America Holdings Liabilities
- Laboratory Corporation of America Holdings Equity
- Laboratory Corporation of America Holdings AAQS
- Laboratory Corporation of America Holdings Employees
- Laboratory Corporation of America Holdings ROE
- Laboratory Corporation of America Holdings ROA
- Laboratory Corporation of America Holdings ROCE
